Home > News > Do-Coop Technologies Announces New Product
March 30th, 2006
Do-Coop Technologies Announces New Product
Abstract:
Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today the commercial availability of Neowater(TM) - ELISA Enhancer, a new product that increases immunoassay sensitivity and accuracy, while reducing total reaction costs. As with the entire Neowater-based product line, the ELISA Enhancer product is also generic, simple to use, and can be easily incorporated into any type of immunoassays with dramatic results.
Source:
businesswire
Bookmark:
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Less is More: Novel Cellulose Structure Requires Fewer Enzymes to Process Biomass to Fuel June 19th, 2013
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013